Showing results (91-100 of 295) with videos related to

Sort By:
Pageof 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Evolution of the randomized controlled trial in oncology over three decadesChristopher M Booth, David W Cescon, Lisa Wang, et al.
The Oncologist|September 28, 2013
Bevacizumab for advanced breast cancer: hope, hype, and hundreds of headlinesMichael Fralick, Monali Ray, Christina Fung, et al.
World Journal of Urology|February 19, 2017
Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based studyD Robert Siemens, Melanie T Jaeger, Xuejiao Wei, et al.
Clinical Colorectal Cancer|August 1, 2018
Disease Characteristics, Clinical Management, and Outcomes of Young Patients With Colon Cancer: A Population-based StudyLaura Rodriguez, Kelly Brennan, Safiya Karim, et al.
The Lancet. Oncology|January 20, 2025
Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based studyFabio Y Moraes, Andre G Gouveia, Vanessa Freitas Bratti, et al.
The Lancet. Oncology|February 6, 2025
Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trialsBishal Gyawali, Elizabeth A Eisenhauer, Winette van der Graaf, et al.
Canadian Journal of Gastroenterology & Hepatology|March 21, 2022
Rising Healthcare Costs and Utilization among Young Adults with Cirrhosis in Ontario: A Population-Based StudyJeffrey B Ames, Maya Djerboua, Norah A Terrault, et al.
JAMA Oncology|July 8, 2021
Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of ERBB2-Positive Metastatic Breast CancerJosee-Lyne Ethier, Danielle Desautels, Andrew Robinson, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 23, 2020
Management of rectal cancer in Canada: an evidence-based comparison of clinical practice guidelinesZuhaib M. Mir, David Yu, Shaila J. Merchant, et al.
Hepatology (Baltimore, Md.)|June 26, 2021
NAFLD and Alcohol-Associated Liver Disease Will Be Responsible for Almost All New Diagnoses of Cirrhosis in Canada by 2040Jennifer A Flemming, Maya Djerboua, Patti A Groome, et al.
Pageof 30